TYE-2001

N/A

Report date: 2024/01/16 17:48:04

Base Information

Drug NameTYE-2001
Drug Alias NameTYE-2001
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionSomatostatin receptor 2 modulators
TargetsSomatostatin receptor 2
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Tyercan Bio-pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Tyercan Bio-pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPsoriasisLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A